Currently predicting for Thu, 4 Jun 2026

GNPX Prediction Chart

GNPX Predictions History

Latest community submissions for GNPX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 24, 2025 $11.30 +23.37% $9.61 V 82.40% 1
Oct 24, 2025 $10.50 +14.61% $9.61 V 90.76% 1
Oct 24, 2025 $11.00 +0.36% $9.61 X 85.54% 1
Oct 22, 2025 $13.78 +19.84% $10.96 X 74.26% 0
Oct 22, 2025 $12.93 +12.40% $10.96 X 82.06% 0
Oct 22, 2025 Bearish $10.96 V 1
Oct 17, 2025 $0.429 -9.82% $0.363 V 81.84% 1
Oct 17, 2025 $0.446 -6.14% $0.363 V 77.02% 1
Oct 17, 2025 Bullish $0.363 X 0
Oct 17, 2025 Bearish $0.363 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GNPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GENPREX INC.
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE